Celgene Corporation
(NASDAQ : CELG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.57%93.761.3%$1006.11m
BIIBBiogen Inc.
-0.35%226.391.3%$952.73m
AMGNAmgen Inc.
-2.74%177.471.3%$455.04m
GILDGilead Sciences, Inc.
-0.47%62.950.9%$420.88m
ILMNIllumina, Inc.
0.11%319.033.5%$281.15m
REGNRegeneron Pharmaceuticals, Inc.
-2.81%333.342.6%$259.19m
VRTXVertex Pharmaceuticals Incorporated
0.71%168.161.9%$237.18m
ALXNAlexion Pharmaceuticals, Inc.
0.08%126.012.0%$169.88m
ONCESpark Therapeutics, Inc.
-0.08%110.6211.2%$168.64m
EXASExact Sciences Corporation
0.44%92.2125.3%$159.86m
SRPTSarepta Therapeutics, Inc.
-1.76%116.6414.7%$145.69m
AAgilent Technologies, Inc.
0.99%76.181.6%$128.52m
INCYIncyte Corporation
-0.48%73.962.5%$95.36m
IONSIonis Pharmaceuticals, Inc.
0.44%72.998.3%$93.24m
BMRNBioMarin Pharmaceutical Inc.
0.98%83.164.3%$89.86m

Company Profile

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.